Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2020

Diluted earnings per share for the three and nine months ended September 30, 2020 and 2019 includes the effect of potential common shares issuable when dilutive, and is as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019 (as restated)		2020		2019 (as restated)
Net (loss) income	$	4,178	$	7,180	$	(32,913)	$	23,312
Weighted average number of common shares outstanding (in '000s)	30,986		30,581		30,894		30,547
Dilutive effect of restricted stock grants after application of the Treasury Stock Method (in '000s)	631		271		—		282
Dilutive shares outstanding	31,617		30,852		30,894		30,829
Basic (loss) earnings per share	$	0.13	$	0.23	$	(1.07)	$	0.76
Diluted (loss) earnings per share	$	0.13	$	0.23	$	(1.07)	$	0.76

Schedule of Stockholders Equity

The changes in stockholder's equity are as follows:


	Nine Months Ended September 30, 2020
	Common Stock			Treasury Stock		Additional Paid In Capital		Retained Deficit		Accumulated Other Comp. Loss		Total CVG Stockholders’ Equity
	Shares	Amount
Balance - December 31, 2019	30,801,255	$	323	$	(11,230)	$	245,852	$	(60,307)	$	(45,950)	$	128,688
Share-based compensation expense	46,014	—		—		862		—		—		862
Total comprehensive income	—	—		—		—		(24,594)		(8,030)		(32,624)
Balance - March 31, 2020	30,847,269	$	323	$	(11,230)	$	246,714	$	(84,901)	$	(53,980)	$	96,926
Share-based compensation expense	138,400	(14)		—		868		—		—		854
Total comprehensive income	—	—		—		—		(12,497)		2,578		(9,919)
Balance - June 30, 2020	30,985,669	$	309	$	(11,230)	$	247,582	$	(97,398)	$	(51,402)	$	87,861
Share-based compensation expense	—	1		—		741		—		—		742
Total comprehensive income	—	—		—		—		4,178		2,564		6,742
Balance - September 30, 2020	30,985,669	$	310	$	(11,230)	$	248,323	$	(93,220)	$	(48,838)	$	95,345


	Nine Months Ended September 30, 2019
	Common Stock			Treasury Stock		Additional Paid In Capital		Retained Deficit 1		Accumulated Other Comp. Loss		Total CVG Stockholders’ Equity
	Shares	Amount
Balance - December 31, 2018 (as restated)	30,512,843	$	318	$	(10,245)	$	243,007	$	(76,013)	$	(47,471)	$	109,596
Share-based compensation expense	—	—		—		761		—		—		761
Cumulative effect of adoption of Topic 842	—	—		—		—		(72)		—		(72)
Total comprehensive income	—	—		—		—		9,986		(206)		9,780
Balance - March 31, 2019 (as restated)	30,512,843	$	318	$	(10,245)	$	243,768	$	(66,099)	$	(47,677)	$	120,065
Share-based compensation expense	68,431	1		—		718		—		—		719
Total comprehensive income	—	—		—		—		6,146		1,955		8,101
Balance - June 30, 2019 (as restated)	30,581,274	$	319	$	(10,245)	$	244,486	$	(59,953)	$	(45,722)	$	128,885
Share-based compensation expense	—	—		—		721		—		—		721
Total comprehensive income	—	—		—		—		7,180		(5,998)		1,182
Balance - September 30, 2019 (as restated)	30,581,274	$	319	$	(10,245)	$	245,207	$	(52,773)	$	(51,720)	$	130,788

1.The Company has adjusted certain prior period amounts for the restatement and immaterial corrections of error. See Note 3, Restatement of Previously Issued Consolidated Financial Statements for details.